XML 22 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Options And Stock Grants
12 Months Ended
Dec. 31, 2011
Stock Options And Stock Grants [Abstract]  
Stock Options And Stock Grants

(11) Stock Options and Stock Grants

We have entered into stock option agreements with certain officers, employees and directors. The stock options generally expire ten years from the date of grant.

Employees Stock Options

The Company follows FASB ASC Topic 718, Share-Based Payments, in which compensation expense is recognized only for share-based payments expected to vest. The Company recognized compensation expense related to stock options of $392,153 and $428,009 for the years ended December 31, 2011 and 2010, respectively.

 

As of December 31, 2011, there was approximately $535,000 of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Company's stock option plans. That cost is expected to be recognized over a remaining weighted-average period of 1.9 years.

The following table illustrates the various assumptions used to calculate the Black-Scholes option pricing model for options granted for all years presented:

 

     Years Ended December 31,  
     2011     2010  

Weighted-average risk-free interest rates:

     2.51     2.96

Dividend yield:

     0.00     0.00

Weighted-average expected life of the option:

     7 years        7 years   

Weighted-average expected stock price volatility:

     74.20     79.00

Weighted-average fair value of the options granted:

   $ 0.89      $ 1.23   

The Company uses the Black-Scholes option pricing model to determine the fair value of stock based compensation. The Black-Scholes model requires the Company to make several assumptions, including the estimated length of time employees will retain their vested stock options before exercising them ("expected term"), the estimated volatility of the Company's common stock price over the expected term and estimated forfeitures. Expected price volatility of the fiscal 2011 and 2010 grants is based on the daily market rate changes of the Company's stock going back to January 1, 2004. The shares granted in fiscal 2011 and 2010 had a vesting period of either three or five years and a contractual life of 10 years. Forfeitures were estimated at 4.49% and 4.68% for the years ended December 31, 2011 and 2010, respectively, based on the Company's historical experience. The Black-Scholes model also requires a risk free interest rate, which is based on the U.S. Treasury yield curve in effect at the time of the grant, and the dividend yield on the Company's common stock, which is assumed to be zero since the Company does not pay dividends and has no current plans to do so in the future. Changes in these assumptions can materially affect the estimate of fair value of stock based compensation and consequently, the related expense recognized on the statement of operations. The Company recognizes stock based compensation expense on a straight-line basis.

The following table summarizes the Company's option activity for Nanophase Technologies Corporation employees and directors during the year ended December 31, 2011:

 

Options

   Shares     Weighted
Average
Exercise
Price per
Share
     Weighted
Average
Remaining
Contractual
Term (years)
     Aggregate
Intrinsic
Value
 

Outstanding on January 1, 2011

     1,270,500      $ 3.34         

Granted

     524,500      $ 1.27         

Exercised

     (4,000   $ 1.02         

Forfeited or expired

     (203,568     5.78         
  

 

 

         

Outstanding on December 31, 2011

     1,587,432      $ 2.47         7.10         —     
  

 

 

         

Exercisable on December 31, 2011

     808,384      $ 3.50         5.50         —     
  

 

 

         

Shares available for grant

     1,604,905           
  

 

 

         

 

The aggregate intrinsic value in the table above is zero, based on Nanophase's closing stock price of $0.41 on the last business day for the period ended December 31, 2011.

During the years ended December 31, 2011 and 2010 the total intrinsic value of Nanophase stock options exercised was $560 and $0, respectively. Cash received for option exercises was $4,080 and $0 during the years ended December 31, 2011 and 2010, respectively. We had 4,000 options exercised during the year ended December 31, 2011, compared to 0 in 2010. Based on the Company's election of the "with and without" approach, no realized tax benefits from stock options were recognized for the years ended December 31, 2011 and 2010.

During 2011, 203,568 stock options were forfeited primarily due to expirations.

Stock Appreciation Rights

During the years ended December 31, 2011 and 2010, the Company granted its outside directors stock appreciation rights (SAR's) totaling 0 and 61,000 shares, respectively, under the Company's Amended and Restated 2006 Stock Appreciation Rights Plan. The fair value of the awards granted during 2010 was $46,335, the 2011 decrease in valuation for prior awards was $70,284 and is included in non-cash compensation expense for the year ended December 31, 2011. The SAR's granted vested immediately and are payable upon the directors' removal or resignation from the position of director. During 2011, Mr. Donald Perkins retired from the Board of Directors and received a cash payment related to this program of $165. These awards are accounted for as liability awards, included in accrued expenses as of December 31, 2011 and 2010, and adjusted to fair value each reporting period. The fair value of the liability on December 31, 2011 and 2010 is $10,873 and $81,157, respectively.

Restricted Stock

As of December 31, 2011 and 2010, respectively, the Company did not have any unvested non-director restricted stock or performance shares outstanding.